Detalles de la búsqueda
1.
Association of hepatitis B virus DNA levels with overall survival for advanced hepatitis B virus-related hepatocellular carcinoma under immune checkpoint inhibitor therapy.
Cancer Immunol Immunother
; 72(2): 385-395, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35907016
2.
The inter-link of ageing, cancer and immunity: findings from real-world retrospective study.
Immun Ageing
; 20(1): 75, 2023 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38102684
3.
Immune-related pneumonitis requiring low-dose prednisone maintenance in one patient with durable complete response.
J Oncol Pharm Pract
; 29(4): 986-991, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36120899
4.
CircPCBP2 promotes the stemness and chemoresistance of DLBCL via targeting miR-33a/b to disinhibit PD-L1.
Cancer Sci
; 113(8): 2888-2903, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35579082
5.
Efficacy and Safety of Apatinib in Patients with Recurrent or Refractory Melanoma.
Oncologist
; 27(6): e463-e470, 2022 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35348754
6.
Long-term survival of a patient with microsatellite-stable refractory colorectal cancer with regorafenib and PD-1 inhibitor sintilimab: a case report and review of literature.
BMC Gastroenterol
; 21(1): 399, 2021 Oct 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34688262
7.
Heterogeneity in the relationship between carbon emission performance and urbanization: evidence from China.
Mitig Adapt Strateg Glob Chang
; 25(7): 1363-1380, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33071599
8.
Exploring a Tumor-Intrinsic PD-L1 Signal with Proximity-Dependent Biotin Identification in Lung Cancer Cells.
Biochemistry
; 58(18): 2293-2296, 2019 05 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31021072
9.
Angiotensin-(1-7)-mediated Mas1 receptor/NF-κB-p65 signaling is involved in a cigarette smoke-induced chronic obstructive pulmonary disease mouse model.
Environ Toxicol
; 33(1): 5-15, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28960804
10.
Neoadjuvant chemoimmunotherapy in locally advanced gastric or gastroesophageal junction adenocarcinoma.
Front Oncol
; 14: 1342162, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38686192
11.
Emerging markets' response to COVID-19: Insights from arbitrages strategies.
Heliyon
; 10(10): e30876, 2024 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38779004
12.
The efficacy of subsequent therapy after failure of anti-PD-1 antibody in metastatic renal cell carcinoma.
Transl Cancer Res
; 13(5): 2238-2250, 2024 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38881916
13.
The effect of heterogeneous environmental regulations on the employment skill structure: The system-GMM approach and mediation model.
PLoS One
; 18(8): e0290276, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37616229
14.
Predictive factors for inadequate stem cell mobilization in Chinese patients with NHL and HL: 14-year experience of a single-center study.
J Clin Apher
; 27(2): 64-74, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22298390
15.
[Efficacy analysis of third-generation plus platinum doublets in the first-line chemotherapy of advanced non-small cell lung cancer].
Zhonghua Yi Xue Za Zhi
; 92(22): 1527-31, 2012 Jun 12.
Artículo
en Zh
| MEDLINE | ID: mdl-22944054
16.
[Detection of epidermal growth factor receptor gene mutations in advanced non-small cell lung cancer].
Zhonghua Bing Li Xue Za Zhi
; 41(8): 530-3, 2012 Aug.
Artículo
en Zh
| MEDLINE | ID: mdl-23157744
17.
Complete remission of ovarian clear cell carcinoma achieved after pseudoprogression during PD-1 inhibitor therapy.
Immunotherapy
; 14(15): 1205-1209, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36043370
18.
Sintilimab maintenance therapy post first-line cytokine-induced killer cells plus chemotherapy for extensive-stage small cell lung cancer.
Front Oncol
; 12: 852885, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36158690
19.
Combination of Low-Dose Gemcitabine and PD-1 Inhibitors for Treatment in Patients With Advanced Malignancies.
Front Immunol
; 13: 882172, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35911715
20.
[Factors affecting the sensitivity of EGFR-TKI treatment in advanced non-small cell lung cancer].
Zhonghua Zhong Liu Za Zhi
; 33(3): 217-21, 2011 Mar.
Artículo
en Zh
| MEDLINE | ID: mdl-21575523